| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |